Castle Biosciences (CSTL) Free Cash Flow Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) Free Cash Flow Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 51.58% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 16.06% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 112.68% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 87.85% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 23.29% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -20.33% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | -21.08% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 33.01% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 5.28% |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | -43.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -43.32% |
| Mar 31, 2026 | -143.37% |
| Dec 31, 2025 | 87.44% |
| Sep 30, 2025 | -98.30% |
| Jun 30, 2025 | 81.65% |
| Mar 31, 2025 | -43.03% |
| Dec 31, 2024 | -12.82% |
| Sep 30, 2024 | 1,313.73% |
| Jun 30, 2024 | 231.90% |
| Mar 31, 2024 | 73.82% |
| Dec 31, 2023 | 358.92% |
| Sep 30, 2023 | 156.22% |
| Jun 30, 2023 | 27.42% |
| Mar 31, 2023 | -34.08% |
| Dec 31, 2022 | -300.19% |
| Sep 30, 2022 | 28.04% |
| Jun 30, 2022 | -89.35% |
| Mar 31, 2022 | -389.89% |
| Dec 31, 2021 | -171.42% |
| Sep 30, 2021 | -30.01% |